Literature DB >> 21570297

A 10-year retrospective study of hemangioblastomas of the central nervous system with reference to von Hippel-Lindau (VHL) disease.

Somanath Padhi1, Rajlaxmi Sarangi, Sundaram Challa, Priyatamjee Bussary, Manas K Panigrahi, Anirudh K Purohit.   

Abstract

We aimed to analyze the clinical, radiological, surgicopathological and clinical outcome data of patients who underwent surgery for central nervous system (CNS) hemangioblastoma (HBL) with or without von Hippel-Lindau (VHL) disease. The clinico pathological and radiological findings, management and clinical outcome of patients with CNS HBL (operated between 2000 and 2009) were analyzed retrospectively. The differences between sporadic and VHL-associated HBL were analyzed. Forty-nine patients (28 male, 21 female) underwent surgery for CNS hemangioblastoma. Thirty-nine patients (80%) harbored sporadic HBL whereas 10 (20%) had VHL disease. The mean age at diagnosis for VHL-associated HBL was 32 years when compared to 40 years in sporadic HBL. The lesions were solitary in 41 patients and multiple in eight. The cerebellum was the most common site of HBL (35/49, 71%). Six patients with sporadic and two with VHL disease had spinal lesions. On imaging (available in 43/49 patients), a cyst with a mural nodule was the most common finding, seen in 16 patients (37.2%) whereas nine patients (21%) had solid and cystic lesions. Clinical presentation, radiological features, and histomorphology of HBL with or without VHL disease were similar. Multiple cysts in the pancreas, kidney, broad ligament, epididymis, clear cell renal cell carcinoma, phaeochromocytoma and retinal angiomas were the visceral manifestations seen in patients with VHL disease. Of all patients with VHL disease, three required multiple surgeries for new lesions and one died of renal failure and sepsis. Among the patients with sporadic disease (31/39), two died of surgical complications, one died of postoperative sepsis, three were lost to follow-up and the remainder had resolution of symptoms at 1year following surgery. We concluded that the diagnosis of VHL disease is important as management is more difficult and lifelong follow-up and counseling are required in these patients and for their at-risk relatives.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21570297     DOI: 10.1016/j.jocn.2010.12.050

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  13 in total

1.  Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.

Authors:  Taekmin Kwon; In Gab Jeong; Sahyun Pak; Dalsan You; Cheryn Song; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

2.  Epidemiological study of a von Hippel-Lindau family in northwest China.

Authors:  Jingyao Zhang; Dapeng Wu; Hong Ai; Jigang Bai; Shunbin Dong; Qinling Yang; Kai Qu; Lei Zhou; Xinsen Xu; Chang Liu
Journal:  Front Med       Date:  2013-07-05       Impact factor: 4.592

3.  Development of a small solid cerebellar haemangioblastoma into a large pseudocyst with a mural nodule in a patient without VHL; the importance of regular follow-up.

Authors:  Hansol Kim; Jin-Deok Joo; Young-Hoon Kim; Chae-Yong Kim
Journal:  BMJ Case Rep       Date:  2014-11-26

4.  Genotype-phenotype analysis of von Hippel-Lindau syndrome in fifteen Indian families.

Authors:  Narendranath Vikkath; Sindhu Valiyaveedan; Sheela Nampoothiri; Natasha Radhakrishnan; Gopal S Pillai; Vasantha Nair; Ginil Kumar Pooleri; Georgie Mathew; Krishnakumar N Menon; Prasanth S Ariyannur; Ashok B Pillai
Journal:  Fam Cancer       Date:  2015-12       Impact factor: 2.375

5.  Differentiation of hemangioblastomas from pilocytic astrocytomas using 3-T magnetic resonance perfusion-weighted imaging and MR spectroscopy.

Authors:  D J She; Z Xing; Z Zeng; X Y Shang; D R Cao
Journal:  Neuroradiology       Date:  2014-12-07       Impact factor: 2.804

Review 6.  Surgical resection of sporadic and hereditary hemangioblastoma: Our 10-year experience and a literature review.

Authors:  Elisabeth Bründl; Petra Schödel; Odo-Winfried Ullrich; Alexander Brawanski; Karl-Michael Schebesch
Journal:  Surg Neurol Int       Date:  2014-09-22

7.  Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.

Authors:  Jee-Soo Lee; Ji-Hyun Lee; Kyu Eun Lee; Jung Hee Kim; Joon Mo Hong; Eun Kyung Ra; Soo Hyun Seo; Seung Jun Lee; Man Jin Kim; Sung Sup Park; Moon-Woo Seong
Journal:  BMC Med Genet       Date:  2016-07-20       Impact factor: 2.103

8.  Surgical treatment of cerebellar hemangioblastomas.

Authors:  A Cervio; J F Villalonga; R Mormandi; S Condomí Alcorta; G Sevlever; J Salvat
Journal:  Surg Neurol Int       Date:  2017-08-01

9.  Hemangioblastoma located in the posterior incisural space mimicking a tentorial meningioma: a case report.

Authors:  Alejandra T Rabadán; Diego A Hernández; Leonardo Paz
Journal:  J Med Case Rep       Date:  2016-06-23

10.  Assessment of care pattern and outcome in hemangioblastoma.

Authors:  Yuqian Huang; Lilian Chan; Harrison X Bai; Xuejun Li; Zishu Zhang; Yinyan Wang; Ya Cao; Giorgos Karakousis; Raymond Huang; Bo Xiao; Paul J Zhang; Li Yang
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.